Kairos Therapeutics - Ownership and Business Overview

Life ScienceCompany

Kairos Therapeutics Ownership

Who owns Kairos Therapeutics?

Kairos Therapeutics is owned by Zymeworks. It was acquired on March 22, 2016.

Kairos Therapeutics Business Overview

Where is Kairos Therapeutics headquartered?

Kairos Therapeutics is headquartered in Vancouver, British Columbia.

What sector is Kairos Therapeutics in?

Kairos Therapeutics is a life science company.

When was Kairos Therapeutics founded?

Kairos Therapeutics was founded in 2013.

Life Science M&A Summary in 2016

Out of 60 sectors in the Mergr database, life science ranked 8 in number of deals in 2016. The largest life science acquisition in 2016 was Baxalta - which was acquired by Shire for $32.0B.

Join Mergr to view all 292 acquisitions of life science companies in 2016, including 31 acquisitions by private equity firms, and 261 by strategics.

Kairos Therapeutics, Inc.

2405 Wesbrook Mall, Fourth Floor,
Vancouver, British Columbia V6T 1Z3
Canada,
(604) 827-1213
www.kairostherapeutics.com

Kairos Therapeutics, Inc. is a bio pharmaceutical company specialists in the discovery and development of antibody drug conjugates (ADCs), spun out of The Centre for Drug Research and Development (CDRD).


 Subscribe to unlock this and 201,688
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.5K Private Equity Firms
  • 193K M&A Transactions
  • 197K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 75K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.